Ann: Veyonda Survival Advantage in LuPSMA Therapy Confirmed, page-20

  1. 7,515 Posts.
    lightbulb Created with Sketch. 337
    The human body is obviously not a mouse - we obviously have size differences by multiples - imagine the poor mouse having a suppository! I get the human tumour but this can be grown in the lab why put them in a mouse - how is that relevant to a human? if the compound attacks the tumour in a test tube then what is the point of putting that tumour into a mouse who is then given the compound/s?
    I guess safety wise its a good idea to test it on a poor mouse before using it on a human but the human tumour is still a human tumour - it came from a human (presumably), putting it into a mouse with the differences in anatomy and physiology and diet and environment and DNA etc etc etc I would think is not a great indicator of how it would behave in a human - safety yes no argument. (having said that sometimes this is not the case in that what doesn't hurt a mouse can sometimes hurt a human as described in the below article)

    Why Drugs Tested in Mice Fail in Human Clinical Trials

    https://sitn.hms.harvard.edu/flash/2020/why-drugs-tested-in-mice-fail-in-human-clinical-trials/

    Last edited by Pbnewby: 13/08/21
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
6.8¢
Change
0.000(0.00%)
Mkt cap ! $19.87M
Open High Low Value Volume
6.7¢ 6.8¢ 6.7¢ $540 8.021K

Buyers (Bids)

No. Vol. Price($)
2 89402 6.7¢
 

Sellers (Offers)

Price($) Vol. No.
6.8¢ 52835 2
View Market Depth
Last trade - 10.20am 21/07/2025 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.